Gilead Sciences, Inc. (GILD)
SIX
Real-time Data
07:00 AM
Day's Range
120.1852 wk Range
98.58Overview - GILD - Gilead Sciences, Inc.
Key Statistics
Valuation
Enterprise Value
144.68B
P/E (Trailing)
‪18.68‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪4.69‬
Price / Book
‪14.81‬
EV / EBITDA
‪12.03‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
1.23B
Held by Insiders
‪0.11%‬
Held by Institutions
‪92.22%‬
Price stats
Beta
‪0.35‬
50-Day Avg
‪114.02‬
200-Day Avg
‪109.66‬
Dividends
Payout Ratio
‪11.16%‬
Frequency
Quarterly
Market Cap - GILD - Gilead Sciences, Inc.
Peers - GILD - Gilead Sciences, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
Profile Summary - GILD - Gilead Sciences, Inc.
About
Gilead Sciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious diseases with unmet medical needs. Gilead Sciences specializes in therapeutic areas including HIV, viral hepatitis, oncology, inflammation, respiratory conditions, and cardiovascular…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
